News

I don’t think they’re needed,” said George Tidmarsh, head of the FDA’s Center for Drug Evaluation and Research.
The FDA will convene experts on Nov. 6 to discuss challenges around regulating mental health products that use artificial ...
The FDA will hold its first Digital Health Advisory Committee (DHAC) meeting to discuss how the agency should review medical devices that rely on generative AI, like chatbots. The meeting will be ...
The FDA is moving to scale back its long-standing use of expert panels to review drug applications, KFF Health News reported Sept. 12. George Tidmarsh, MD, PhD, director of the FDA’s Center for Drug ...
RFK Jr. critic and vaccine expert Paul Offit responds to his abrupt removal from the FDA’s vaccine advisory committee The ...
Paul Offit, longtime member of the FDA’s vaccine advisory committee and an outspoken critic of Health Secretary Robert F.
WASHINGTON -- Those worried about catching the flu got some good news on Friday. Tamiflu is still considered safe and effective in reducing the severity of the illness. An advisory committee to the ...
Dr. Paul Offit, a frequent critic of US Health and Human Services Secretary Robert F. Kennedy Jr., has been blocked from ...
A Food and Drug Administration panel recommended approval yesterday of the first in a new generation of treatments for psoriasis, a decision welcomed by people with that disfiguring ailment -- and ...